Bellevue Group AG

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1674546 Zurich, V8

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$123,665,167

-$7,898,209 QoQ

Shares Held

6,731,909

+0.1% QoQ

Ownership

5.94%

of shares outstanding

% of Portfolio

2.68%

of 13F equity value

Holder Rank

of 214 holders

Holding Since

Jun 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. VRDN ranks #7 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	578,634	$287,424,866
2	ARGX	Argenx SE	301,000	$279,258,770
3	RVMD	Revolution Medicines, Inc.	1,048,014	$196,272,061
4	ORKA	Oruka Therapeutics, Inc.	1,657,190	$157,714,772
5	INSM	INSMED Inc	1,393,418	$148,566,226
6	SRRK	Scholar Rock Holding Corp	2,449,547	$134,725,085
7	VRDN	Viridian Therapeutics, Inc.\DE This page	6,731,909	$123,665,167
8	RLAY	Relay Therapeutics, Inc.	6,185,970	$115,739,498

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$123,665,167	6,731,909	+0.1%	Shares	Defined	2026-08-14
2026-03-31	$131,563,376	6,726,144	—	Shares	Sole	2026-05-15
2026-03-31	$131,563,376	6,726,144	+54.3%	Shares	Defined	2026-05-15
2025-12-31	$135,637,360	4,358,527	+22719.5%	Shares	Defined	2026-02-17
2024-03-31	$334,441	19,100	-36.3%	Shares	Defined	2024-05-15
2023-12-31	$653,400	30,000	-53.0%	Shares	Defined	2024-02-14
2023-09-30	$978,231	63,770	+43.6%	Shares	Defined	2023-11-14
2023-06-30	$1,056,276	44,400	-3.7%	Shares	Defined	2023-08-14
2023-03-31	$1,172,784	46,100	0.0%	Shares	Defined	2023-05-15
2022-12-31	$1,346,581	46,100	0.0%	Shares	Defined	2023-02-14
2022-09-30	$945,511	46,100	-5.9%	Shares	Defined	2022-11-14
2022-06-30	$566,930	49,000	—	Shares	Defined	2022-08-11
No filing history on record for this holder in this stock.